michael atkins, md, on follow up investigation of checkmate 025 in renal cell carcinoma patients
Published 4 years ago • 37 plays • Length 0:44
Download video MP4
Download video MP3
Similar videos
-
2:01
michael atkins, md, discusses checkmate-214 investigating nivolumab ipilimumab in rcc patients
-
1:58
dr. plimack on significance of checkmate-025 trial in rcc
-
0:58
michael atkins, md, regarding the keynote 426 phase iii trial in metastatic renal cell carcinoma
-
2:53
michael b. atkins, md, regarding the long-term follow up of checkmate-004 in metastatic melanoma
-
0:51
michael atkins, md, shares exciting potential of current late-stage clinical studies in rcc patients
-
1:20
michael atkins, md, offers opinion on io-tki combinations in renal cell cancer
-
0:55
michael atkins, md, on mrcc patients whose cancer returns and were previously treated with i-o
-
0:41
michael atkins, md, on appropriate patient types to receive a tki in the treatment of 1st line rcc
-
3:52
checkmate 025: phase 3 trial of nivolumab for advanced kidney cancer
-
8:32
dr. michael b. atkins on treating advanced kidney cancer
-
1:46
clinical trials in kidney cancer to look out for
-
1:31
combining immunotherapy with vegf inhibitors to treat kidney cancer
-
1:48
checkmate 205: 5 year follow-up of nivolumab in hl
-
11:23
new targets, new pathways michael b. atkins, m.d.
-
1:42
dr. mcdermott on immotion150 trial in rcc
-
1:33
checkmate 920: nivolumab plus ipilimumab for renal cell cancer
-
3:47
other clinical trials in renal cell carcinoma
-
1:06
dr. mckay discusses the checkmate-214 trial in rcc
-
5:06
phase 3 checkmate - 214
Clip.africa.com - Privacy-policy